BioVex's Acquisition

BioVex was acquired by Amgen on January 25, 2011.

BioVex is a biotechnology company that develops vaccines. The company develops vaccines for the treatment of cancer and chronic infectious diseases. BioVex has two proprietary vaccine platforms; OncoV…

Articles about BioVex's Acquisition: